Novel PET Imaging Techniques in the Management of Hematologic Malignancies, An Issue of PET Clinics
- 1 Edición, Volumen 19-4 - 30 de agosto de 2024
- Última edición
- Editores: Cristina Nanni, Paolo Castellucci, Stefano Fanti, Neeta Pandit-Taskar
- Idioma: Inglés
In this issue of PET Clinics, guest editors Drs. Cristina Nanni, Paolo Castellucci, Stefano Fanti, and Neeta Pandit-Taskar bring their considerable expertise to the topic of Novel… Leer más
In this issue of PET Clinics, guest editors Drs. Cristina Nanni, Paolo Castellucci, Stefano Fanti, and Neeta Pandit-Taskar bring their considerable expertise to the topic of Novel PET Imaging Techniques in the Management of Hematological Malignancies. Top experts in the field discuss the latest radiotracers for lymphoma and myeloma, novel quantitative imaging techniques, radioligand therapies, total body PET imaging; and more.
- Contains 15 relevant, practice-oriented topics including PET imaging for therapy assessment in Hodgkin and non-Hodgkin lymphomas; symptomatic myeloma: PET, WB-MRI with DWI or both; advantages of total body PET imaging in hematological malignancies; applications of FDG-PET imaging in leukemias; PET imaging for therapy assessment in symptomatic myeloma, including Minimal Residual Disease; and more.
- Provides in-depth clinical reviews on novel PET imaging techniques in the management of hematological malignancies, offering actionable insights for clinical practice.
- Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
Nuclear medicine radiologists
2-deoxy-2-[18F]FDG PET Imaging for Therapy Assessment in Hodgkin’s and Non-Hodgkin Lymphomas
New PET Tracers for Lymphoma
Radioligand Therapy in Lymphoma: Past, Present, and Future
Long-Axial Field-of-View PET Imaging in Patients with Lymphoma: Challenges and Opportunities
FDG-PET/CT Imaging in Chimeric Antigen Receptor–Engineered T-Cell Treatment in Patients with B-Cell Lymphoma: Current Evidence
New PET Tracers for Symptomatic Myeloma
Symptomatic Myeloma: PET, Whole-Body MR Imaging with Diffusion-Weighted Imaging or Both
Applications of 18F-Fluorodesoxyglucose PET Imaging in Leukemia
Role of Novel Quantitative Imaging Techniques in Hematological Malignancies
Lymphoma: The Added Value of Radiomics, Volumes and Global Disease Assessment
PET Imaging in Chimeric Antigen Receptor T-Cell Trafficking
New PET Tracers for Lymphoma
Radioligand Therapy in Lymphoma: Past, Present, and Future
Long-Axial Field-of-View PET Imaging in Patients with Lymphoma: Challenges and Opportunities
FDG-PET/CT Imaging in Chimeric Antigen Receptor–Engineered T-Cell Treatment in Patients with B-Cell Lymphoma: Current Evidence
New PET Tracers for Symptomatic Myeloma
Symptomatic Myeloma: PET, Whole-Body MR Imaging with Diffusion-Weighted Imaging or Both
Applications of 18F-Fluorodesoxyglucose PET Imaging in Leukemia
Role of Novel Quantitative Imaging Techniques in Hematological Malignancies
Lymphoma: The Added Value of Radiomics, Volumes and Global Disease Assessment
PET Imaging in Chimeric Antigen Receptor T-Cell Trafficking
- Edición: 1
- Última edición
- Volumen: 19-4
- Publicado: 2 de septiembre de 2024
- Idioma: Inglés
CN
Cristina Nanni
Afiliaciones y experiencia
Nuclear Medicine Department, Intitute of Nuclear Medicine, University of Bologna, ItalyPC
Paolo Castellucci
Afiliaciones y experiencia
Nuclear Medicine
Azienda Ospedaliero?Universitaria di Bologna
University of Bologna
Bologna, ItalySF
Stefano Fanti
Afiliaciones y experiencia
Nuclear Medicine
Azienda Ospedaliero-Universitaria di Bologna
University of Bologna
Bologna, ItalyNP
Neeta Pandit-Taskar
Afiliaciones y experiencia
Parker Institute for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center New York, New York, USA